Document 2694
 DOCN  M94A2694
 TI    Evaluation of a particle agglutination assay for detection of HIV-1
       antibodies.
 DT    9412
 AU    Ferreira LA; Ferreira JA; Berro OJ; Sykora R; Shimauchi A; Fujino R;
       Nacional Program of STD/AIDS, Rio de Janeiro, Brazil.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):246 (abstract no. PB0412). Unique
       Identifier : AIDSLINE ICA10/94369881
 AB    We evaluated the sensibility, especificity and eficiency of SERODIA-HIV
       particle agglutinatination assay, from Fujirebio Inc., Tokyo, Japan. It
       was tested 49 Seros samples, being 17 from a national panel, produced by
       the Laboratory with a National reference for Retrovirus
       (BIOMANGUINHOS/FIOCRUZ), 12 seros of anti-HIV-1 low titer panel (Boston
       Biomedica Inc.) and 20 samples from the routine of the Public Health
       Central Laboratory Noel Nutels/Rio de Janeiro. The samples were
       considered truly positive or negative in according to the Western Blot
       and the reaction interpretation criteria was that recommended by the
       CDC. From the total of the appraised samples, one remained undetermined
       and the sensibility, especificity and eficiency of the test determined,
       respectively in 100%, 85.7% and 97.9%. There were few variations among
       the lectures achieved by different technicians, without presenting
       significative alterations. The results confirm that the tests Serodia
       can be widely used like a selecting teste for detecting of antibodies
       anti-HIV-1, because of the fact of being simple and consequently not
       needing any equipment to be realized, they present excelent sensibility.
 DE    Agglutination Tests/*METHODS  AIDS Serodiagnosis/*METHODS  Comparative
       Study  Human  HIV Antibodies/*BLOOD  HIV
       Seropositivity/*DIAGNOSIS/IMMUNOLOGY  HIV-1/*IMMUNOLOGY  Japan
       Predictive Value of Tests  Quality Control  Reference Values  MEETING
       ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).